651 filings
Page 21 of 33
8-K
cx2 amtqtmupy4c0nw
26 Oct 12
Other Events
12:00am
8-K
dd2um9pflk5sazeed
24 Oct 12
Material Modifications to Rights of Security Holders
12:00am
8-K
mo1vc8l3uj
23 Oct 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
n50yfb8kzyj 1f
19 Oct 12
Nabi Biopharmaceuticals Announces Exchange Ratio for Proposed Business
12:00am
DEFA14A
iyj6m
19 Oct 12
Additional proxy soliciting materials
12:00am
8-K
6iy 6s62aofygrhp8cm
17 Oct 12
Results of NicVAX®Phase II Study in Combination with Varenicline
12:00am
DEFA14A
w34uuu25h98yldim
17 Oct 12
Additional proxy soliciting materials
12:00am
8-K
mo3xd9f8
16 Oct 12
Nabi Biopharmaceuticals Sets Record Date for Cash Dividend
12:00am
DEFA14A
gi54f 6hyrhji
16 Oct 12
Additional proxy soliciting materials
12:00am
DEFA14A
sjqj08 oof
16 Oct 12
Additional proxy soliciting materials
12:00am
DEFA14A
f35cnl4
15 Oct 12
Additional proxy soliciting materials
12:00am
8-K
vl1pigq9tr
12 Oct 12
Regulation FD Disclosure
12:00am
DEFA14A
2x9e5y6w4 kaqgy
12 Oct 12
Additional proxy soliciting materials
12:00am
DEFA14A
93p8mnhs1
5 Oct 12
Additional proxy soliciting materials
12:00am
DEFA14A
hrs91
26 Sep 12
Additional proxy soliciting materials
12:00am
DEFA14A
ofzo w10bk
25 Sep 12
Additional proxy soliciting materials
12:00am
DEFA14A
ic44c ayxty8zzz8s4xb
25 Sep 12
Additional proxy soliciting materials
12:00am
8-K
24p ypms0
25 Sep 12
Nabi Biopharmaceuticals Announces Adjournment of Special Meeting of
12:00am
DFAN14A
z9ar03yowz8ajohmxae6
20 Sep 12
Additional proxy materials by non-management
12:00am
DEFA14A
ulqv6 bhromf
18 Sep 12
Additional proxy soliciting materials
12:00am